Deidre Alycia Shay, NP
Nurse Practitioner · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Svmhs Clinics · 258 clinicians in this group
Looking this up.
Hospitals listed: Salinas Valley Health Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Deidre Alycia Shay’s office at (831) 758-2100 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Salinas Valley Health Medical CenterSalinas, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Salinas Valley Memorial Healthcare SystemPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for Salinas Valley Health Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.32 (0.34 to 2.3) · 1,159 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.68 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.42 (143.23 to 253.6) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 203 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 536 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,377 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 7,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,999 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.97 (1.83 to 6.1) · 1,428 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.7 (0.16 to 3.24) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.87 to 3.76) · 1,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.78 (3.73 to 15.83) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.23 (1.52 to 8.95) · 453 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.48 (0 to 1.11) · 6,011 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.487 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.082 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.432 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 491 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8 · 660 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 569 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 485 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.2 to 8.4) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 197 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 489 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$4,108
Medicare paid this office $4,108 for 42 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,248 | $54 |
Who their Medicare patients are
42 Original Medicare patients in 2024. Average age 76 · Women 48% · Also on Medicaid 45% · Health risk score 2.09. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 67% · Heart failure 67% · Diabetes 55% · Chronic kidney disease 45% · Atrial fibrillation 36%.
The office billed $12,995, Medicare allowed $5,150 and paid $4,108; for 62 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$4,057
Pharmacies billed $4,057 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 83) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
78 generic and fewer than 11 brand-name prescriptions · $4,057 in drug cost · 24 antibiotic prescriptions to 21 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 11 | $169 | $14 |
| Cephalexin | 17 | $65 | $3 |
Money from drug and device companies
$2,239 in 2025
| 2025 | 12 | 38 | None | $2,239 |
| 2024 | 7 | 8 | None | $356 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Cardiomems | $1,229 | 6 payments
|
| Abiomed | None | $340 | 7 payments
|
| Merck Sharp & Dohme | Verquvo | $218 | 9 payments
|
| Novo Nordisk | Wegovy | $125 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $91 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $69 | 3 payments
|
See all 38 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-12-03 | Kerendia | $25 |
| Abbott Laboratories | Travel · 2025-11-24 | Cardiomems | $46 |
| Abbott Laboratories | Travel · 2025-11-24 | Cardiomems | $383 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-18 | Kerendia | $21 |
| Abiomed | Meals · 2025-11-10 | None | $40 |
| Merck Sharp & Dohme | Meals · 2025-10-24 | Capvaxive | $19 |
| Merck Sharp & Dohme | Meals · 2025-10-08 | Verquvo | $26 |
| Novartis Pharmaceuticals | Meals · 2025-09-27 | Leqvio | $23 |
| Merck Sharp & Dohme | Meals · 2025-09-24 | Verquvo | $29 |
| Cleerly | Meals · 2025-09-17 | Cleerly Ischemia | $21 |
| Merck Sharp & Dohme | Meals · 2025-09-09 | Verquvo | $23 |
| Merck Sharp & Dohme | Meals · 2025-08-22 | Verquvo | $16 |
| Amgen | Meals · 2025-08-20 | Repatha | $14 |
| Abbott Laboratories | Meals · 2025-08-20 | Cardiomems | $72 |
| Abbott Laboratories | Travel · 2025-08-20 | Cardiomems | $125 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-13 | Kerendia | $24 |
| Merck Sharp & Dohme | Meals · 2025-07-30 | Verquvo | $29 |
| Abbott Laboratories | Travel · 2025-07-28 | Cardiomems | $595 |
| Abbott Laboratories | Travel · 2025-07-28 | Cardiomems | $9 |
| Novartis Pharmaceuticals | Meals · 2025-07-02 | Leqvio | $19 |
| Amgen | Meals · 2025-06-18 | Repatha | $22 |
| Edwards Lifesciences | Meals · 2025-06-06 | Sapien 3 Ultra Resilia | $25 |
| Merck Sharp & Dohme | Meals · 2025-06-04 | Verquvo | $28 |
| Merck Sharp & Dohme | Meals · 2025-05-16 | Capvaxive | $30 |
| Novartis Pharmaceuticals | Meals · 2025-04-30 | Leqvio | $28 |
| Merck Sharp & Dohme | Meals · 2025-04-24 | Verquvo | $20 |
| Abiomed | Meals · 2025-04-17 | None | $40 |
| Abiomed | Meals · 2025-04-02 | None | $42 |
| Novo Nordisk | Meals · 2025-03-26 | Wegovy | $125 |
| Novartis Pharmaceuticals | Meals · 2025-03-11 | Leqvio | $21 |
| Abiomed | Meals · 2025-03-06 | None | $13 |
| Boston Scientific | Meals · 2025-02-27 | Cds Broad Portfolio Offering | $28 |
| Scpharmaceuticals | Meals · 2025-02-25 | Furoscix | $24 |
| Amgen | Meals · 2025-02-14 | Repatha | $16 |
| Abiomed | Meals · 2025-02-06 | None | $148 |
| Medtronic | Meals · 2025-02-03 | Azure Xt Dr Mri Surescan | $19 |
| Abiomed | Meals · 2025-01-30 | None | $43 |
| Abiomed | Meals · 2025-01-29 | None | $14 |
See earlier years (2024)
2024: $356
| Novo Nordisk | None | $119 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $104 | 1 payment
|
| Amgen | Repatha | $40 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $25 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $25 | 1 payment
|
| Medtronic | Symplicity G3 | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
Professional record
- NPI
- 1225883119
- Licence
- CA 95028572
- Group
- Svmhs Clinics
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 100 Wilson Rd Ste 100, Monterey, CA, 93940
- NPI first listed
- 2024-04-23
- NPI last updated
- 2024-07-18
- NPI record certified
- 2024-07-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 90 E 3rd St Unit 428, Morgan Hill, CA, 95037